Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM clinical trial (NCT05761301). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ALN-KHK compare to my current diabetes treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM clinical trial (NCT05761301). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM clinical trial (NCT05761301). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits and what will those visits involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM clinical trial (NCT05761301). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM clinical trial (NCT05761301). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there a chance I might receive a placebo instead of the active treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM clinical trial (NCT05761301). Contact the study team or your healthcare provider for specific answers.

What this study is about